Lafadofensine

Lafadofensine (), also known as (3S)-N,N-bis(4-fluorophenyl)pyrrolidin-3-amine, is a drug described as an antidepressant which has not been marketed at this time. It is said to act as a serotonin–norepinephrine–dopamine reuptake inhibitor (SNDRI). The drug was first described by 2010 and its was proposed by 2021.

See also

• List of investigational antidepressants
• 2-Diphenylmethylpyrrolidine
• Desoxypipradrol

References